SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2018 Anaheim, CA
Activity/Course #:
: 08.11.18PC
Cost:
: Free
Release/Start Date:
: Aug 11 2018
Expiration Date:
: Aug 11 2019
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 3.75 pharmacology hour(s)
Hardware/Software Requirements:
Saturday August 11, 2018
Delta Hotels Marriott
12021 Harbor Blvd
Garden Grove, CA 92840
(714) 786-8348
 

Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
Complimentary self-parking is available at the hotel.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning objectives

At the conclusion of this program, participants should be able to:

1. Recognize the pathogenesis of type 2 diabetes (T2DM) as a progressive, multi-defect disorder; Discuss the strengths and limitations of current guidelines for diabetes management; Successfully use strategies for adherence to multiple medications to improve outcomes in diabetes; Examine data on current combination strategies to choose therapies that most effectively address a patient's underlying pathophysiologic needs.

2. Discuss clinician and patient barriers to initiation and intensification of insulin therapy; Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Discuss the pharmacology and clinical differences between existing and new long-acting and concentrated insulins; Discuss how to incorporate new basal and concentrated insulins into clinical practice while minimizing the risk of adverse events.

3. Review the risk factors and classification of pulmonary hypertension (PH); Discuss the appropriate diagnostic strategy for pulmonary arterial hypertension (PAH), including the roles of echocardiography, ventilation/perfusion (V/Q) scanning, and right heart catheterization (RHC); Review current and emerging treatments for patients with PAH; Describe how to monitor patients with PAH for disease progression.

4. Determine the difference between acute and chronic cough to distinguish the different causes; Understand the complications associated with cough; Develop a process to evaluate the cause of chronic cough; Develop a treatment strategy for treatment of acute and chronic cough.

5. Describe the findings from recent trials of PCSK9i hypercholesterolemia treatments on cardiovascular outcomes; Discuss current guidelines and recommendations on the management of hyperlipidemia in high risk patients; Incorporate current data into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Recognize barriers to access for PCSK9 monoclonal antibody therapy and discuss novel strategies to overcome them.

6. Identify blood pressure goals for patients with various comorbidities; Select evidence-based therapy for patients with hypertension; Identify ethnic, racial, and age-related disparities in care of hypertensive patients, as well as strategies to overcome them; Provide evidence-based and guideline-based workup for patients with hypertension.

7. Perform appropriate laboratory tests to diagnose hyperthyroidism and hypothyroidism; Prescribe appropriate therapy for patients with hyperthyroidism and hypothyroidism, and monitor patients accordingly; Identify treatment strategies appropriate for different patients and provide informed consent to assist patients in selecting treatments; Develop an evidence-based screening protocol to identify patients with risk factors for thyroid disorders, and screen appropriately for hyperthyroidism and hypothyroidism.


 

Agenda*

 

 7:30-8:00  
Continental Breakfast and Registration 
 8:00-8:10 Welcome Remarks
Gregg Sherman, MD
 8:10-9:10  The Progression of Type 2 Diabetes: A Rational Approach for Long Term Disease
Management
Jeff Unger, MD, FAAFP, FACE
 9:10-10:10 Safely Achieving Goals in Type 2 Diabetes (T2DM): The Role of Concentrated and Long-
Acting Insulins
Jeff Unger, MD, FAAFP, FACE
 10:10-10:30  Break
 10:30-11:30 Evolving Strategies of Care in Pulmonary Arterial Hypertension: Integrating the Data
into Practice
Alexander Duarte, MD
 11:30-12:30 Evaluation and Management of The Patient with Chronic Cough: What’s the Fuss?
Alexander Duarte, MD
12:30-1:30
 Lunch
 1:30-2:30 Managing Lipids and Cardiovascular Risk: Using the Data to Optimize Care
Karol E. Watson, MD, PhD
 2:30-3:30 Hypertension: I Got Pressure!
David Schneider, MD
 3:30-3:40 Break
 3:40-4:40 Hyperthyroidism and Hypothyroidism: Running Hot and Cold
David Schneider, MD
4:40-4:45
 Program Summary and Closing Remarks
Gregg Sherman, MD

* Agenda subject to change

Faculty

Alexander Duarte, MD
Professor
Division of Pulmonary Critical Care & Sleep Medicine
Department of Internal Medicine
University of Texas Medical Branch
Galveston, TX

David Schneider, MD
Faculty Physician/Medical & Pharmacy Student Clerkship Director
Santa Rosa Family Medicine Residency
Clinical Professor of Family and Community Medicine, UCSF
Clinical Professor of Pharmacy, UCSF School of Pharmacy
Santa Rosa, CA

Jeff Unger, MD, FAAFP, FACE
Assistant Clinical Professor of Family Medicine
UC Riverside School of Medicine
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, CA

Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program
Los Angeles, CA


Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer

Association of Black Cardiologists

New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 contact hours of continuing education, which includes 3.75 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., educational funding provided by Amgen; an educational grant from Sanofi US and Regeneron Pharmaceuticals; an educational grant from Novo Nordisk Inc, and an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.